These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 195728)

  • 21. Ion-pair liquid chromatography of cytarabine and uracil-arabinoside in human plasma.
    Burk M; Volmer M; Fartash K; Schneider W
    Arzneimittelforschung; 1995 May; 45(5):616-9. PubMed ID: 7612064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct evidence for the binding or compartmentalization of acid-soluble metabolites in oocyte cells.
    Merriam RW; Haefele M
    J Cell Physiol; 1966 Oct; 68(2):99-106. PubMed ID: 4290135
    [No Abstract]   [Full Text] [Related]  

  • 23. A radioimmunoassay for 1-beta-D-arabinofuranosylcytosine.
    Okabayashi T; Mihara S; Repke DB; Moffatt JG
    Cancer Res; 1977 Feb; 37(2):619-24. PubMed ID: 832282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new sensitive method for determination of intracellular 1-beta-D-arabinofuranosylcytosine 5'-triphosphate content in human materials in vivo.
    Yamauchi T; Ueda T; Nakamura T
    Cancer Res; 1996 Apr; 56(8):1800-4. PubMed ID: 8620496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of 1-beta-D-arabinofuranosylcytosine incorporation into DNA in vivo.
    Spriggs D; Robbins G; Ohno Y; Kufe D
    Cancer Res; 1987 Dec; 47(24 Pt 1):6532-6. PubMed ID: 3479246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo studies on high-dose 1-beta-D-arabinofuranosylcytosine (HDara-C) and 1-beta-D-arabinofuranosyluracil (ara-U) with respect to pharmacokinetics, cell kinetics, and cytotoxicity in a rat myelocytic leukemia model (BNML).
    Colly LP; Willemze R; Honders W; vd Hoorn F; Edelbroek PM
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):49-54. PubMed ID: 3859932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells.
    Maehara Y; Kusumoto T; Sakaguchi Y; Kusumoto H; Anai H; Sugimachi K
    Anticancer Res; 1989; 9(1):41-4. PubMed ID: 2705754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous determination of cytosine arabinoside, its nucleotides and metabolites by ion-pair high-performance liquid chromatography.
    Schilsky RL; Ordway FS
    J Chromatogr; 1985 Jan; 337(1):63-71. PubMed ID: 3980658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil in human plasma by high-performance liquid chromatography.
    Linssen P; Drenthe-Schonk A; Wessels H; Haanen C
    J Chromatogr; 1981 May; 223(2):371-8. PubMed ID: 7251792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous analysis of 1-beta-D-arabinofuranosylcytosine, 1-beta-D-arabinofuranosyluracil and sodium salicylate in biological samples by high-performance liquid chromatography.
    Liversidge GG; Nishihata T; Higuchi T; Shaffer R; Cortese M
    J Chromatogr; 1983 Sep; 276(2):375-83. PubMed ID: 6630386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Micellar electrokinetic capillary chromatography quantification of cytosine arabinoside and its metabolite, uracil arabinoside, in human serum.
    Houzé P; Deschamps F; Dombret H; Bousquet B; Gourmel B
    J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(1):185-92. PubMed ID: 11318414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and determination of the major metabolites of [3H]cytosine arabinoside by high-performance liquid chromatography.
    Braess J; Pförtner J; Kaufmann CC; Ramsauer B; Unterhalt M; Hiddemann W; Schleyer E
    J Chromatogr B Biomed Appl; 1996 Feb; 676(1):131-40. PubMed ID: 8852053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of the new liposomal anticancer drug N4-octadecyl-1-beta-D-arabinofuranosylcytosine in mice.
    Koller-Lucae SK; Suter MJ; Rentsch KM; Schott H; Schwendener RA
    Drug Metab Dispos; 1999 Mar; 27(3):342-50. PubMed ID: 10064564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N4-chloroacetylcytosine arabinoside--a possible pro-drug of cytosine arabinoside.
    Ariatti M; Jones PA
    Biochem Int; 1987 Dec; 15(6):1097-103. PubMed ID: 3440022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A radioimmunoassay for cytosine arabinoside.
    Piall EM; Aherne GW; Marks VM
    Br J Cancer; 1979 Oct; 40(4):548-56. PubMed ID: 574019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in patients with acute leukemia.
    Ueda T; Nakamura T; Ando S; Kagawa D; Sasada M; Uchino H; Johno I; Akiyama Y
    Cancer Res; 1983 Jul; 43(7):3412-6. PubMed ID: 6850647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and properties of O'-methyl and O'-ethyl derivatives of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil.
    Darzynkiewicz E; Shugar D
    Acta Biochim Pol; 1974; 21(3):305-22. PubMed ID: 4440349
    [No Abstract]   [Full Text] [Related]  

  • 38. Thin-layer separation and quantitative elution of nucleosides and nucleotides.
    Greenman DL; Huang RC; Smith M; Furrow LM
    Anal Biochem; 1969 Oct; 31(1):348-59. PubMed ID: 5382626
    [No Abstract]   [Full Text] [Related]  

  • 39. Nucleic acids. I. The synthesis of nucleotides and dinucleoside phosphates containing ara-cytidine.
    Wechter WJ
    J Med Chem; 1967 Sep; 10(5):762-73. PubMed ID: 4292735
    [No Abstract]   [Full Text] [Related]  

  • 40. Insights into the soluble PEG-supported synthesis of cytosine-containing nucleoside 5'-mono-, di-, and triphosphates.
    Crauste C; Périgaud C; Peyrottes S
    J Org Chem; 2009 Dec; 74(23):9165-72. PubMed ID: 19894748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.